Segment Reporting |
Both our Chief Executive Officer and Executive
Chairman serve as the Chief Operating Decision Maker (“CODM”), organize the Company, manage resource allocations and
measure performance among two operating and reportable segments: (i) Healthcare IT and (ii) Practice Management.
The Healthcare IT
segment includes revenue cycle management and other services. The Practice Management segment includes the management of three
medical practices and starting April 1, 2019, certain practice management services are being provided to a fourth practice. Each
segment is considered a reporting unit. The CODM evaluates financial performance of the business units on the basis of revenue
and direct operating costs excluding unallocated amounts, which are mainly corporate overhead costs. Our CODM does not evaluate
operating segments using asset or liability information. The accounting policies of the segments are the same as those disclosed
in the Company’s Annual Report on Form 10-K for the year ended December 31, 2018 filed with the SEC on March 20, 2019. The
following tables present revenues, operating expenses and operating income (loss) by reportable segment:
|
|
Nine Months Ended September 30, 2019 |
|
|
|
Healthcare IT |
|
|
Practice Management |
|
|
Unallocated Corporate Expenses |
|
|
Total |
|
Net revenue |
|
$ |
38,518,361 |
|
|
$ |
10,162,677 |
|
|
$ |
- |
|
|
$ |
48,681,038 |
|
Operating expenses: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Direct operating costs |
|
|
23,912,120 |
|
|
|
7,867,444 |
|
|
|
- |
|
|
|
31,779,564 |
|
Selling and marketing |
|
|
1,065,750 |
|
|
|
25,774 |
|
|
|
- |
|
|
|
1,091,524 |
|
General and administrative |
|
|
8,549,122 |
|
|
|
1,504,506 |
|
|
|
3,704,177 |
|
|
|
13,757,805 |
|
Research and development |
|
|
648,822 |
|
|
|
- |
|
|
|
- |
|
|
|
648,822 |
|
Change in contingent consideration |
|
|
(343,768 |
) |
|
|
- |
|
|
|
- |
|
|
|
(343,768 |
) |
Depreciation and amortization |
|
|
2,170,204 |
|
|
|
236,907 |
|
|
|
- |
|
|
|
2,407,111 |
|
Restructuring and impairment charges |
|
|
136,332 |
|
|
|
- |
|
|
|
- |
|
|
|
136,332 |
|
Total operating expenses |
|
|
36,138,582 |
|
|
|
9,634,631 |
|
|
|
3,704,177 |
|
|
|
49,477,390 |
|
Operating income (loss) |
|
$ |
2,379,779 |
|
|
$ |
528,046 |
|
|
$ |
(3,704,177 |
) |
|
$ |
(796,352 |
) |
|
|
Three Months Ended September 30, 2019 |
|
|
|
Healthcare IT |
|
|
Practice Management |
|
|
Unallocated Corporate Expenses |
|
|
Total |
|
Net revenue |
|
$ |
12,938,042 |
|
|
$ |
3,913,286 |
|
|
$ |
- |
|
|
$ |
16,851,328 |
|
Operating expenses: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Direct operating costs |
|
|
7,508,208 |
|
|
|
3,027,421 |
|
|
|
- |
|
|
|
10,535,629 |
|
Selling and marketing |
|
|
339,603 |
|
|
|
7,965 |
|
|
|
- |
|
|
|
347,568 |
|
General and administrative |
|
|
2,791,573 |
|
|
|
548,746 |
|
|
|
1,111,656 |
|
|
|
4,451,975 |
|
Research and development |
|
|
175,758 |
|
|
|
- |
|
|
|
- |
|
|
|
175,758 |
|
Change in contingent consideration |
|
|
(279,565 |
) |
|
|
- |
|
|
|
- |
|
|
|
(279,565 |
) |
Depreciation and amortization |
|
|
735,133 |
|
|
|
79,077 |
|
|
|
- |
|
|
|
814,210 |
|
Restructuring and impairment charges |
|
|
136,332 |
|
|
|
- |
|
|
|
- |
|
|
|
136,332 |
|
Total operating expenses |
|
|
11,407,042 |
|
|
|
3,663,209 |
|
|
|
1,111,656 |
|
|
|
16,181,907 |
|
Operating income (loss) |
|
$ |
1,531,000 |
|
|
$ |
250,077 |
|
|
$ |
(1,111,656 |
) |
|
$ |
669,421 |
|
|
|
Nine Months Ended September 30, 2018 |
|
|
|
Healthcare IT |
|
|
Practice Management |
|
|
Unallocated Corporate Expenses |
|
|
Total |
|
Net revenue |
|
$ |
30,720,367 |
|
|
$ |
3,314,421 |
|
|
$ |
- |
|
|
$ |
34,034,788 |
|
Operating expenses: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Direct operating costs |
|
|
18,303,270 |
|
|
|
2,638,265 |
|
|
|
- |
|
|
|
20,941,535 |
|
Selling and marketing |
|
|
1,159,943 |
|
|
|
9,640 |
|
|
|
- |
|
|
|
1,169,583 |
|
General and administrative |
|
|
6,591,165 |
|
|
|
552,514 |
|
|
|
3,642,555 |
|
|
|
10,786,234 |
|
Research and development |
|
|
768,517 |
|
|
|
- |
|
|
|
- |
|
|
|
768,517 |
|
Change in contingent consideration |
|
|
68,253 |
|
|
|
- |
|
|
|
- |
|
|
|
68,253 |
|
Depreciation and amortization |
|
|
1,890,809 |
|
|
|
81,756 |
|
|
|
- |
|
|
|
1,972,565 |
|
Total operating expenses |
|
|
28,781,957 |
|
|
|
3,282,175 |
|
|
|
3,642,555 |
|
|
|
35,706,687 |
|
Operating income (loss) |
|
$ |
1,938,410 |
|
|
$ |
32,246 |
|
|
$ |
(3,642,555 |
) |
|
$ |
(1,671,899 |
) |
|
|
Three Months Ended September 30, 2018 |
|
|
|
Healthcare IT |
|
|
Practice Management |
|
|
Unallocated Corporate Expenses |
|
|
Total |
|
Net revenue |
|
$ |
13,730,105 |
|
|
$ |
3,314,421 |
|
|
$ |
- |
|
|
$ |
17,044,526 |
|
Operating expenses: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Direct operating costs |
|
|
9,485,642 |
|
|
|
2,638,265 |
|
|
|
- |
|
|
|
12,123,907 |
|
Selling and marketing |
|
|
451,872 |
|
|
|
9,640 |
|
|
|
- |
|
|
|
461,512 |
|
General and administrative |
|
|
2,730,595 |
|
|
|
552,514 |
|
|
|
1,848,186 |
|
|
|
5,131,295 |
|
Research and development |
|
|
263,717 |
|
|
|
- |
|
|
|
- |
|
|
|
263,717 |
|
Change in contingent consideration |
|
|
25,473 |
|
|
|
- |
|
|
|
- |
|
|
|
25,473 |
|
Depreciation and amortization |
|
|
740,342 |
|
|
|
81,756 |
|
|
|
- |
|
|
|
822,098 |
|
Total operating expenses |
|
|
13,697,641 |
|
|
|
3,282,175 |
|
|
|
1,848,186 |
|
|
|
18,828,002 |
|
Operating income (loss) |
|
$ |
32,464 |
|
|
$ |
32,246 |
|
|
$ |
(1,848,186 |
) |
|
$ |
(1,783,476 |
) |
|